menu

Medical Program: Comparing Combination Therapies for Lung Cancer: Rationales & Risks

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Comparing Combination Therapies for Lung Cancer: Rationales & Risks

close
Comparing Combination Therapies for Lung Cancer: Rationales & Risks
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Here to explain how our refined understandings of driver mutations, immune properties, and tumor microenvironments have changed the way we think about combination therapies, their benefits and limitations, and what’s on the horizon is Dr. Jonathan Riess, Associate Professor of Oncology and Hematology at the UC Davis Medical Center. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Here to explain how our refined understandings of driver mutations, immune properties, and tumor microenvironments have changed the way we think about combination therapies, their benefits and limitations, and what’s on the horizon is Dr. Jonathan Riess, Associate Professor of Oncology and Hematology at the UC Davis Medical Center. 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/11/20